Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20230405057822N1Phase 3Completed
Phase 3, randomised, double-blind trial of atropine and neostigmine (3 arms), sponsored by Shahid Sadoughi University of Medical Sciences. Primary endpoint: Pulse rate. Started Oct 2021; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20230405057822N1.